Tweet
Share
Myworld |
Sign Up
|
Login
Home
Browse
Featured
Latest
Popular
Templates
Patients
Blog
Clinical profile of dengue hemorrhagic fever cases in Mexico.
×
Send This
Download
Comment
Favourite
more
Add to your Conference/Group
Please Select--
Add your comments:
Insert YouTube Videos inside your Slideworld presentation Copy and paste the video URL from YouTube, choose where to insert the video, and press “Submit”. The video will play in your slideshow after sometime.
Enter YouTube video URL
Enter Slide No where you want to insert youtube videos
Rating :
Rate It:
Embed :
Post a comment
Post Comment on Twitter
Post Comment on SlideWorld
Comments:
Subscribe to follow-up comments
SlideWorld will not store your password. SlideWorld will maintain your privacy.
Twitter Username:
Twitter Password:
Comments:
Email:
Subscribe to follow-up comments
Notes
Show Notes
Hide Notes
Slide 1 :
Clinical profile of dengue hemorrhagic fever cases in Mexico. Joel Navarrete-Espinosa, MD (1) Héctor Gómez-Dantés, MD (2) Juan Germán Celis-Quintal (2) José Luis Vázquez-Martínez (2) (1) Coordinación de Programas Integrados de Salud, USP, Instituto Mexicano del Seguro Social (IMSS). (2) División Técnica en Estadísticas de Salud, IMSS.
Slide 2 :
Objectives: To describe the clinical behavior of Dengue fever (DF) and Dengue hemorrhagic fever (DHF). To determine some of the risk factors associated with the occurrence of hemorrhagic forms and fatal cases in the population attended by the Mexican Institute of Social Security (IMSS).
Slide 3 :
Material and Methods Follow-up study Patients were cases diagnosed as DF or DHF confirmed by a serological test (IgM ELISA). Clinical and epidemiological data were obtained from the case report format. Two groups were formed according to their clinical evolution and following the WHO/PAHO established criteria: DF (including dengue fever with hemorrhagic manifestations cases) and DHF (including fatal cases). The information was validated and analyzed to calculate simple frequencies, central tendency and dispersion measures. Cumulative incidence and relative risk were estimated along with their 95% confidence intervals (CI 95%). The statistical analysis to compare groups was performed using the Kruskal-Wallis test and Poisson regression.
Slide 4 :
Results
Slide 5 :
Table I
Slide 6 :
Table II
Slide 7 :
Slide 8 :
Table III
Slide 9 :
Table IV
Slide 10 :
Discussion
Slide 11 :
Clinical studies differed in the spectrum of signs and symptoms reported and usually emphasized those that are more prominent in the population studied. Report of dengue hemorrhagic cases (DHF) in the IMSS demonstrated that severe dengue infection is usually accompanied by more than one bleeding site (30%) and that gastrointestinal bleeding as well as petechia and epistaxis were prominent signs. Dengue shock syndrome (DSS) reported higher prevalence of hepatomegaly (16% in adults and 60% in children) than dengue hemorrhagic fever without complications (7% in adults and 22% in children). Abdominal pain, nausea and vomit are among the alarm signs –digestive syndrome- that revealed the imminent evolution towards severity. In the multivariate analysis the risk factors that appeared predictive of severity and indicated a major risk for death were: echymosis, hematomas, ascitis, hematemesis and melena.
Slide 12 :
The continuous monitoring of thrombocytopenia and hemoconcentration should be viewed as an obligatory procedure and not only as a diagnostic criterion. Thrombocytopenia was present in 100% of the cases, while hemoconcentration was documented in only 12% of them. An important finding is the proportion in which both events are registered simultaneously and the risk to develop DHF and death from this cause. The frequency of these parameters depends on the form corporal fluids are lost during the infection, hemorrhages or plasma leakage, and time in which laboratory test are requested. Global case fatality rate in the IMSS (2.9%) is smaller than the reported in Cuba (5.8% in 1977), Puerto Rico (5.2% in 1991), the French Guyana (15% in 1991) and India (33% in 1988). Data provided by studies like this should help the physicians and the public health service to improve the dengue surveillance system and the prevention of this emergent infectious disease.
Pharmacologic Stress...
PTCA Clinical Trial
Case presentation At...
A Hands On Approach ...
Error in Patient Car...
Immunizations 101 A ...
Free Powerpoint Templates
joel.navarrete@imss.gob.mx
4 Years ago.
1084 Views, 0 favourite
PowerPoint Presentation on Clinical profile of dengue hemorrhagic fever cases in Mexico. or PowerPo
more
PowerPoint Presentation on Clinical profile of dengue hemorrhagic fever cases in Mexico. or PowerPoint Presentation on
less
More By User
Flag as inappropriate
Select your reason for flagging this presentation as inappropriate. If needed, use the
feedback
form to let us know more details.
None
Pornographic
Defamatory
Illegal/Unlawful
Other Terms Of Service Violation
Copy Right
Cancel
Browse
|
Powerpoint Templates
|
Tags
|
Contact
|
About Us
|
Privacy
|
FAQ
|
Blog
© Slideworld